KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Interest Expenses (2016 - 2025)

Elevance Health (ELV) has disclosed Interest Expenses for 17 consecutive years, with $341.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Interest Expenses rose 21.79% to $341.0 million in Q2 2025 year-over-year; TTM through Dec 2025 was $685.0 million, a 42.19% decrease, with the full-year FY2025 number at $1.4 billion, up 18.31% from a year prior.
  • Interest Expenses was $341.0 million for Q2 2025 at Elevance Health, down from $344.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $344.0 million in Q1 2025 to a low of $192.0 million in Q1 2021.
  • A 5-year average of $251.9 million and a median of $240.0 million in 2022 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: dropped 1.03% in 2021, then increased 29.81% in 2025.
  • Elevance Health's Interest Expenses stood at $200.0 million in 2021, then grew by 14.5% to $229.0 million in 2022, then rose by 13.97% to $261.0 million in 2023, then soared by 30.27% to $340.0 million in 2024, then rose by 0.29% to $341.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Interest Expenses are $341.0 million (Q2 2025), $344.0 million (Q1 2025), and $340.0 million (Q4 2024).